StockData
Johnson & Johnson logo

Johnson & Johnson

JNJNYSEPharmaceutical PreparationsFiscal year ends January 3
Financials through Q2 FY2026, quarter ended Jun 28, 2026Last filing: 10-Q on Oct 21, 2026Score 12/3042% above fair value
$270.56−2.64 (-0.97%)

Close on Nov 2, 2026Market cap $652.02BP/E 31.4Yield 1.90%

Johnson & Johnson TRACLEER [reported separately through FY2019Q4] by Year

TRACLEER (bosentan) [reported separately through FY2019Q4] — Worldwide currency (FX) impact YoY (%) (%)

QuarterlyAnnual

Johnson & Johnson TRACLEER [reported separately through FY2019Q4]: 1.0% in FY2018. No newer figure appears in the documents we track.

Latest, FY2018
1.0%
Period ended Dec 30, 2018
Change on a year earlier
–
History
1 years
Since FY2018
Sources
1
Form 8-K (a2018q4exhibit9915.htm, filed 2019-01-22)

Where the FY2018 figure comes from

“|| WW | 546 | 403 | 35.5 | 34.5 | 1.0”

Source: Form 8-K (a2018q4exhibit9915.htm, filed 2019-01-22) ↗

Reported in Form 8-K EX-99.2 Segment Sales Schedule.

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedTRACLEER (bosentan) [reported separately through FY2019Q4] — Worldwide currency (FX) impact YoY (%) (%)Year on yearSource
FY2018Dec 30, 20181.0%–Form 8-K (a2018q4exhibit9915.htm, filed 2019-01-22) ↗

Cite this data

StockData. (2026). Johnson & Johnson TRACLEER [reported separately through FY2019Q4] (%), annual FY2018–FY2018 [Data set]. Compiled from Johnson & Johnson SEC filings and investor materials. https://stockdatahq.com/stocks/jnj/kpis/drug-tracleer-fx-yoy

See every metric in the Johnson & Johnson KPI table. Data updated Oct 25, 2026.